U.S. Communications Stock News

Event context and recent stock move BioMarin Pharmaceutical (BMRN) has drawn investor attention after recent trading, with the stock up about 2.5% on the day and 4.4% over the past week, while longer term returns remain weaker. See our latest analysis for BioMarin Pharmaceutical. The latest move sits against a mixed backdrop, with the share price down about 10% over the past three months and year to date, while the 1-year total shareholder return is also slightly negative. This pattern...

In the past week, Williams Companies reported first-quarter 2026 results that exceeded expectations, reaffirmed its 2026 adjusted EBITDA outlook, and raised its annualized dividend by 5%, supported by stronger volumes, higher rates, and pipeline expansions across key segments, particularly Transmission, Power & Gulf. Analyst commentary highlighting continued growth in Williams’ core pipeline network and the resilience of its dividend policy underscores how recent operating gains may be...

EOG Resources (EOG) delivered first quarter 2026 results that topped revenue and adjusted EPS expectations, yet the stock slipped after management outlined flat Q2 production, softer NGL pricing, and only modestly higher full year output. See our latest analysis for EOG Resources. Despite the initial share price drop after earnings, EOG Resources now trades at US$141.50, with a year to date share price return of 31.91% and a five year total shareholder return of 111.02%. This suggests that...

Recent share performance puts Blackstone in focus Blackstone (BX) has drawn attention after its stock declined about 10% over the past month and roughly 5% over the past 3 months, placing recent performance in the context of its longer term track record. See our latest analysis for Blackstone. With the share price at $110.28, Blackstone’s recent loss of momentum, including a 1-day share price return of down 4.03% and year to date share price return of down 30.55%, contrasts with a 3-year...

Why Public Service Enterprise Group is on investors’ radar today Public Service Enterprise Group (PEG) has moved lower recently, with the stock down about 3% over the past month and around 7% in the past 3 months, prompting a closer look at its current setup. See our latest analysis for Public Service Enterprise Group. At a share price of $77.75, PEG’s recent pullback, including a 30-day share price return of down 3.36% and a 90-day move of down 7.35%, contrasts with its 3-year total...

In early June 2026, MasTec drew attention as valuation services flagged the stock as significantly overvalued and insider sales reached about US$3.5 million over three months with no offsetting insider purchases. This combination of valuation concerns and insider activity has sharpened investor focus on how MasTec’s growth opportunities in grid, data center, and clean energy projects balance against perceived risk. We’ll now examine how insider selling alongside strong infrastructure demand...

In late May 2026, Madrigal Pharmaceuticals reported new Phase 3 and real‑world data at the EASL Congress showing its MASH drug Rezdiffra lowered cardiovascular risk markers, improved liver risk scores in cirrhotic patients, and reduced liver stiffness in routine clinical practice. These findings highlight Rezdiffra’s potential to address both liver disease progression and broader cardiometabolic risk, adding clinical depth beyond traditional histologic endpoints in MASH. We’ll now examine...

Krystal Biotech (KRYS) shares moved after the company reported first quarter 2026 results, with earnings per share above estimates and revenue growth tied to strong Vyjuvek uptake, and reaffirmed expense guidance. See our latest analysis for Krystal Biotech. The stock has built solid momentum over the past year, with a 1-year total shareholder return of 128.6% and a year to date share price return of 22.24%. The latest 1-day move of 2.94% after earnings suggests investors are reassessing...

International Flavors & Fragrances Inc. has agreed to sell its Food Ingredients business to funds advised by CVC Capital Partners for about US$4.30 billion, while retaining roughly a 10% stake and a board seat, and LMR Naturals by IFF has opened a new experimental field in Grasse to advance research into sustainable natural ingredients. Together, the divestiture and the Grasse R&D investment highlight IFF’s push to refocus on its Taste, Scent and Health & Biosciences portfolio while...

Duolingo recently reported past first-quarter 2026 results that exceeded revenue and earnings estimates, supported by strong user and subscriber growth and ongoing profitability. The company highlighted an AI-first push to speed content creation and expand into new educational subjects, aiming to deepen engagement and diversify revenue beyond language learning. Next, we will examine how Duolingo's AI-driven product advancements and investment priorities influence its existing investment...

Wondering whether American Homes 4 Rent is fairly priced or offering hidden value at current levels? This article walks through the key clues in the valuation data so you can judge for yourself. The stock recently closed at US$32.24, with returns of 0.5% over the past week, 0.8% over the past month, a 1.0% gain year to date, but a decline of 10.0% over the past year and 5.5% over five years. Recent coverage has focused on American Homes 4 Rent as part of broader conversations about listed...

PBF Energy has recently completed a US$500 million senior, unsecured, unsubordinated fixed‑rate bond offering, issuing 7.25% notes due June 1, 2034 under Regulation S and Rule 144A. This sizeable debt raise highlights how PBF is accessing credit markets to support its balance sheet flexibility and longer-term funding needs. We’ll now assess how the new US$500 million senior notes may influence PBF Energy’s investment narrative and future risk-reward profile. This technology could replace...

In late May 2026, SEI Investments’ board declared a regular semi-annual dividend of US$0.52 per share and appointed industry veteran Nathan Shetty as Chief Investment Officer, effective June 1, 2026, while also presenting its outlook at the William Blair Growth Stock Conference. These moves, coming on the heels of a strong first quarter with earnings and revenue ahead of expectations, signal a reinforced emphasis on scalable, customized investment solutions and integrated asset management...

Serve Robotics (SERV) drew fresh investor attention after announcing a new urban delivery partnership with on-demand laundry service NoScrubs, its first commercial deployment beyond prepared food deliveries. See our latest analysis for Serve Robotics. Despite the new NoScrubs partnership opening up a fresh use case for its delivery robots, Serve Robotics’ share price has retreated, with the year to date share price return down 30.35% and the 1 year total shareholder return down 31.67%. If...

The Morning Bull - US Market Morning Update Thursday, Jun, 4 2026 US stock futures are slightly softer this morning, with key contracts such as the S&P 500 mini down around 0.1%, as investors weigh weaker global growth signals against stronger pockets of demand. The OECD now sees global growth at 2.8% in 2026 and around 2.0% for the US. In plain terms, this suggests a cooler but still growing world economy. At the same time, oil data show US crude inventories falling by 6.8 million barrels,...

Pinnacle West Capital recently completed a US$499.58 million fixed-income offering of 4.650% senior unsecured notes due June 1, 2029, priced at 99.915% of par and callable, with proceeds earmarked primarily for repaying maturing floating-rate notes, commercial paper, and general corporate purposes. This refinancing, alongside the closure of a US$40.75 million common stock shelf registration linked to its dividend reinvestment plan, highlights management’s focus on fine-tuning the company’s...

Investors may be wondering if Main Street Capital at around US$50.71 is offering fair value right now, or if the current price is out of line with its fundamentals. The stock is down 0.8% over the past week, 9.1% over the past month, and 17.9% year to date, while the 3 year and 5 year returns sit at 59.0% and 77.3% respectively. Recent commentary around business development companies and income focused funds has put fresh attention on dividend sustainability, payout policies, and the role of...

Investors may be wondering whether Starbucks at around US$95.89 is offering good value right now, or just serving up more froth than substance. The stock is up 14.2% year to date and 11.7% over the past year, even though it has fallen 6.1% in the last week and 8.7% over the past month. Recent headlines have focused on Starbucks as a mature consumer brand in a competitive global coffee market, with ongoing attention on store growth, brand strength and consumer demand patterns. These themes...

Alnylam Pharmaceuticals (NasdaqGS:ALNY) has announced a new collaboration with AI firm Inceptive Nucleics focused on accelerating RNAi drug discovery. The partnership will apply generative AI models to RNAi drug design with the goal of improving research productivity and speed for new therapeutics. This AI collaboration is positioned as an important step in advancing Alnylam's Alnylam 2030 strategy. For investors tracking Alnylam Pharmaceuticals at a share price of $292.58, this AI...

In the past few days, Paycom Software has been hit with a securities fraud class action lawsuit alleging it concealed how its Beti payroll product reduced demand for other services and contributed to revenue shortfalls. The case brings fresh scrutiny to how new products like Beti interact with existing revenue streams, and whether management’s disclosures fully captured that trade-off for investors. We’ll now examine how these allegations about Beti’s impact on Paycom’s revenues and...

Recent share performance and why investors are paying attention Bath & Body Works (BBWI) has been on investors’ radar after a period of weaker share performance, with the stock down 3.7% over the past day and 19.2% over the past 3 months. See our latest analysis for Bath & Body Works. At a share price of US$18.02, Bath & Body Works has seen selling pressure build, with the 7-day share price return down 7.35% and the 1-year total shareholder return down 30.96%. This points to fading momentum...

Wondering if Ollie's Bargain Outlet Holdings at around US$79.74 is a bargain or a value trap? This article breaks down what the current price might actually be telling you. The stock is up 1.4% over the past week, although it is down 3.3% over the past month, 28.4% year to date and 30.3% over the last year, which can change how investors think about both its potential and its risk. These moves come as investors continue to weigh the broader outlook for off price retailers and...

Agios Pharmaceuticals (AGIO) stock is in focus after the company signed an exclusive global licensing agreement with Oscotec for cevidoplenib, an oral SYK inhibitor targeting immune thrombocytopenia and other potential indications. See our latest analysis for Agios Pharmaceuticals. The cevidoplenib deal lands at a time when the share price is US$27.68, with a 1-day share price return of 4.41% but a 1-year total shareholder return that has fallen 18.66%. This suggests that recent momentum has...

Gartner (IT) is back in focus after a series of high profile company events on AI adoption and security risk, drawing fresh attention to how its research and conferences connect with current enterprise priorities. See our latest analysis for Gartner. Against this backdrop of AI and security focused events, Gartner’s share price has recently bounced with an 11.54% 30 day share price return and 2.99% 7 day share price return. However, this follows a much weaker year to date share price return...